Turkish Journal of Biology
Volume 44

Number 6

Article 6

1-1-2020

Sex effect on the correlation of immunoglobulin G glycosylation
with rheumatoid arthritis disease activity
ALTAN ERCAN

Follow this and additional works at: https://journals.tubitak.gov.tr/biology
Part of the Biology Commons

Recommended Citation
ERCAN, ALTAN (2020) "Sex effect on the correlation of immunoglobulin G glycosylation with rheumatoid
arthritis disease activity," Turkish Journal of Biology: Vol. 44: No. 6, Article 6. https://doi.org/10.3906/
biy-2005-7
Available at: https://journals.tubitak.gov.tr/biology/vol44/iss6/6

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Biology by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Turkish Journal of Biology
http://journals.tubitak.gov.tr/biology/

Research Article

Turk J Biol
(2020) 44: 406-416
© TÜBİTAK
doi:10.3906/biy-2005-7

Sex effect on the correlation of immunoglobulin G glycosylation with rheumatoid
arthritis disease activity
Altan ERCAN
Department of Molecular Biology and Genetics, Faculty of Life and Natural Sciences, Abdullah Gül University, Kayseri, Turkey
Received: 04.05.2020

Accepted/Published Online: 18.09.2020

Final Version: 14.12.2020

Abstract: Rheumatoid arthritis (RA) is a chronic autoimmune disease which affects females more than males with a presence of autoantibodies. Immunoglobulin G (IgG) produced by adaptive arm has 2 functional domains, Fc and Fab. The Fc domain binds Fc gamma
receptors and C1q proteins of the innate arm. Therefore, the IgG Fc domain serves as a bridge between the innate and adaptive arms
and is regulated by an evolutionarily conserved N-glycosylation with variable structures. These glycans are classified as agalactosylated
G0, monogalactosylated G1, and digalactosylated G2, which are further modified by core-fucosylation (F) and bisecting N-acetylglucosamine (B) moieties such as G0F and G0FB. Interestingly, proinflammatory G0F is shown to be regulated by estrogen in vivo. Here,
it is hypothesized that the regulation of G0F by estrogen contributes to sex dichotomy in RA by setting up the level of IgG-dependent
inflammation and therefore, RA disease activity (Das28-CRP3). To investigate this hypothesis, IgG glycosylation was characterized in
serum samples from active RA patients (n = 232) and healthy controls (n = 232) by serum N-glycan analysis using the high performance
liquid chromatography. According to the results, the IgG Fc glycan phenotype originates predominantly from the structure of G0F, and
both G0F and G0FB correlate with Das28-CRP3 in females, but not in males. In conclusion, IgG G0F-dependent inflammation differs
in males and females, and these differences point to the differential regulation of inflammation by sex hormone estrogen via IgG glycosylation.
Key words: IgG, glycosylation, sex, immune response, inflammation

1. Introduction
Rheumatoid arthritis (RA) is a chronic autoimmune
disease with unknown etiology affecting 0.5%–1.0%
of the world population and more females than males
with a ratio of 3 to 1 (Silman and Pearson, 2002). RA is
characterized by the presence of autoantibodies such
as rheumatoid factor (RF) and anticitrulline peptide
(ACCP), the inflammation of the joints, and damage to
cartilage and bone tissue in the joints (Young et al., 1979;
Wozniczko-Orlowska and Milgrom, 1982; Hassfeld et al.,
1989; Masson-Bessiere et al., 2001; Van Boekel et al., 2002;
Vossenaar et al., 2004; Matsuo et al., 2006; Skriner et al.,
2006; Verpoort et al., 2007; Hueber et al., 2009; Uysal et
al., 2009; Smolen et al., 2016). Immunoglobulin G (IgG)
is the second most abundant protein in the blood and a
glycoprotein that provides the link between the 2 distinct
arms of the immune system, the innate and the adaptive
arms.
IgG is produced by the complex interactions between
T and B cells (Allen et al., 2007; Biram et al., 2019; De Silva
and Klein, 2015; Victora and Nussenzweig, 2012; Suan

et al., 2017). IgG consists of 2 heavy and 2 light chains
resulting in 2 functional domains, Fc and Fab connected
by the flexible hinge region (Figure 1) (Harris et al., 1997;
Schroeder and Cavacini, 2010; Jefferis, 2012; Vidarsson et
al., 2014; Jay et al., 2018). While the Fab domain binds to
the antigen with high affinity, the Fc domain initiates the
IgG-dependent cell and complement-dependent cytotoxic
pathways by stimulating the innate arm of the immune
system (Pincetic et al., 2014; Vidarsson et al., 2014;
Bournazos and Ravetch, 2017; Peschke et al., 2017; Quast
et al., 2017). The IgG Fc domain contains an evolutionarily
conserved N-glycan attached to Asparagine 297 residue
(Figure 1a) (Taylor et al., 2009; Bournazos and Ravetch,
2017; Bournazos, 2019). This N-glycan is a complex twoantenna structure which begins with N-acetylglucosamine
(GlcNAc) and is elaborated by the addition of GlcNAc,
mannose, GlcNAc, and galactose capped with sialic acid
(Figure 1b) (Watson et al., 1999; Jefferis, 2012).
N-glycan in the IgG Fc domain is heterogeneous,
which results from the differential activity of synthetic
glycosyltransferases during its production, and has been
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Figure 1. Structure of IgG and Fc glycans. (A) Shown above is the crystal structure of IgG. IgG consists of two heavy
chain (blue), two light chain (gray) and oligosaccharide (red and white balls). The functional parts (Fc, Fab and
hinge) of IgG formed by these heavy and light chains are shown with vertical lines suitable for their sizes. This figure
is generated form crystal structure in PDB data bank file 1IGT using Viewer Lite software. (B) The fully (top) and
partially (bottom) processed IgG Fc glycan structures and the glycan monomers forming this structure are shown
(top-right corner).

historically classified with respect to the galactose content
as no galactose (G0), one galactose (G1), and 2 galactose
(G2) (Figure 1b) (Axford, 1999). This N-glycan contains
at least 36 different structures when characterized using
liquid chromatographic techniques (Royle et al., 2008). In
healthy people, these glycan structures G0 and G2 vary
between 20% and 40%, while G1 is around 40% (Holland
et al., 2006).
IgG N-glycan is different from the other known
glycans. In general, glycans decorate the outer surface
of the proteins, but N-glycan in the IgG Fc fragment is
sequestered in a aspace formed by 2 heavy chains of IgG
(Figure 1a) (Harris et al., 1997; Gagneux and Varki, 1999;
Raju and Lang, 2014). In this space, N-glycans modify
the outer surface of the IgG Fc domain and thus affect
the binding affinity of the IgG Fc fragment toward the Fc
gamma receptors (Lund et al., 1990; Malhotra et al., 1995;
Anthony et al., 2011; Ahmed et al., 2014; Subedi et al.,
2014; Nandakumar et al., 2018). Therefore, the variation on
the IgG Fc glycan alters IgG-dependent immune response
such as antibody-dependent cell cytotoxicity (Lund et al.,
1990; Malhotra et al., 1995; Anthony et al., 2011; Ahmed et
al., 2014; Subedi et al., 2014; Nandakumar et al., 2018). In
addition, less processed IgG Fc N-glycan structures, which
do not contain galactose and end with GlcNAc (G0),

activate the mannose-dependent lectin pathway, resulting
in complement-dependent cytotoxicity (Malhotra et al.,
1995). In short, the data in the literature prove that different
IgG Fc N-glycan structures lead to different physiological
outcomes (Malhotra et al., 1995; Kaneko et al., 2006;
Anthony and Ravetch, 2010; Ferrara et al., 2011; Golay et
al., 2013; Nandakumar, 2018; Nandakumar et al., 2018).
It is even suggested that fully processed IgG Fc glycan
ending up with sialic acid is antiinflammatory (Kaneko et
al., 2006; Anthony et al., 2011; Ahmed et al., 2014).
This different glycan structure results from the
differential regulation of the glycosyltransferase and
glycosidase enzyme activities in the endoplasmic
reticulum-golgi (ER-Golgi) during the synthesis and
secretion of IgG in B cells. With a limited data on
the literature, it is also possible that IgG N-glycans in
circulating blood can be processed by glycosyltransferases
(Pagan et al., 2018). The data in the literature point to
health status and hormone levels as the source of these
different glycan structures, though not in a detailed way
(Van de Geijn et al., 2009; Wang et al., 2011; Bondt et al.,
2013; Ercan et al., 2017). The most striking one among the
studies about hormonal regulation of IgG glycosylation is
the control of IgG galactosylation by estrogen in both men
and women (Ercan et al., 2017).
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RA is an autoimmune disease that begins with the
wrongful activation of the adaptive arm of the immune
system for unknown reasons, which results in the
production of antibodies specific for autoantigens. In RA,
it was demonstrated that ACCP antibodies are present in
serum at least 4.1 years before the diagnosis of RA (Holers,
2007). Studies with RA animal models have undoubtedly
proven the importance of autoantibodies in the onset and
progression of RA, especially in the antibody-dependent
K/BxN mouse model (Matsumoto et al., 2002; Monach et
al., 2004; Monach et al., 2008). For example, the phenotype
of RA disease can be transferred from a K/BxN mouse
with active RA to a naive C57BL/6 mouse by transferring
the IgG purified from the serum of the K/BxN mouse with
active RA ( Korganow et al., 1999; Maccioni et al., 2002;
Matsumoto et al., 2002; Ditzel, 2004; Monach et al., 2004).
In addition, the transfer of immune cells without B cells
from an arthritic DBA/1 mouse fails to initiate an RA-like
phenotype in anaive B and T cell-deficient SCID mouse,
providing evidence for the importance of the adaptive arm
of the immune system and the production of IgG without
a doubt (Tanaka-Watanabe et al., 2009). This is further
supported by autoantibodies such as anti-CCP and RF in
humans, which successfully serve as a biomarker for the
diagnosis of RA, and this points to the importance of IgG
in disease mechanism (Atzeni et al., 2017).
IgG Fc glycosylation determines the severity of IgGdependent immune response which strongly correlates
with the level of G0t, a combination of agalactosylated
G0F and G0FB glycan structures. As the level of G0t
increases, the cumulative score of disease activity (Das28CRP3) increases (Malhotra et al., 1995; Kaneko et al.,
2006; Arnold et al., 2006; Arnold et al., 2007; Nandakumar
et al., 2007; Anthony et al., 2008; Anthony and Ravetch,
2010). Interestingly, a group of researchers including the
author of the present study proved that the galactosylation
of IgG is controlled by estrogen (Ercan et al., 2017). In
addition, a sex-dependent correlation was noted between
G0t and Das28-CRP3, which is present in females but not

in males (Ercan et al., 2010). Here, it is hypothesized that
the correlation between Das28-CRP3 and G0t originates
from the G0F glycan structure and this is sex-dependent.
To investigate this hypothesis, the correlation of Das28CRP3 with G0F and G0FB glycan structures is examined
in detail focusing on sex difference.
2. Materials and methods
2.1. Study population
Serum samples for the IgG glycan analysis were obtained
from the patient sample bank of the Brigham Rheumatoid
Arthritis Sequential Study (BRASS). The BRASS cohort
characteristics are described in detail in the study by
Ercan et al. (2010). Briefly, the serum samples used in
this study were taken from active RA patients treated at
Brigham and Women’s Hospital (Table). After obtaining
the blood samples, the serum samples were generated and
kept frozen at −80 °C until it was used. The effects of freeze
and thaw cycles on the IgG glycan were analyzed and
no effects were observed. Age- and sex-matched serum
samples from anonymous healthy people were used as
controls for the BRASS RA cohort. The cohort properties
of these examples are summarized in Table. This study was
approved by the Brigham and Women’s Hospital ethics
committee.
2.2. Determination of glycan peaks belonging to IgG in
serum sample
To identify the glycan structures originating from IgG, 3
samples were generated and characterized for each serum
sample (the original serum sample, the IgG-depleted
serum sample, and the purified IgG). For the purification
of IgG from the serum sample, Protein G-Sepharose beads
were used because it binds to IgG with very high affinity
and specificity. First, the Protein G beads were equilibrated
with 100 mM Tris-HCl pH 7.5 on the benchtop. Then, the
serum sample was applied to the column. The material
that passed through the column without interacting is the
IgG-depleted serum sample. Then, the column was washed
with 100 mM Tris-HCl pH 7.5 buffer 5 times the volume

Table. Characteristics of the cohorts.
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BRASS RA patients
(n =232)

Healthy controls
(n = 232)

Age (years) average ± SD

57.9 ± 12.8

52.6 ± 14.1

Female (%)

119 (51.3)

119 (51.3)

Das28-CRP3 average ± SD

4.145 ± 1.725

—

G0t average ± SD

1.36 ± 0.41

1.01 ± 0.23

G0F average ± SD

0.85 ± 0.34

0.61 ± 0.19

G0F average ± SD

0.50 ± 0.13

0.40 ± 0.10
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of the column to get rid of the residual unbound materials.
The IgG bond to Protein G beads was eluted with 100 mM
Acetic acid at pH 2.5. As soon as the sample was eluted
from the column, the pH of the sample was adjusted to pH
7.5 by the addition of 1.5 M Tris-HCl at pH 10. This sample
was a purified IgG. The serum, IgG-depleted serum, and
protein G purified IgG samples were analyzed by the
serum N-glycan analysis using high performance liquid
chromatography (HPLC) (Royle et al., 2008; Ercan et al.,
2010). According to their profiles, the N-glycan structures
of IgG were determined.
2.3. Serum IgG N-glycan analysis
The N-glycan analysis of the serum samples from RA
patients and healthy controls were performed by the
serum HPLC-based N-glycan analysis (Royle et al.,
2008; Ercan et al., 2010). The serum samples (5 µL) were
transferred to each well of a polypropylene flat-bottomed
96-well microplate. The serum samples were mixed with
2 µL of sample buffer containing 1 mL of 10% SDS, 0.625
mL of 0.5 M Tris-HCl, pH 6.6, 3.4 mL of water, 2 µL of
water, and 1 µL of 0.5 M dithiothreitol. Following the
incubation of the samples at 65 °C for 15 min to reduce
proteins, the samples were alkylated by the addition of 1
µL of 100 mM iodoacetamide followed by incubation at
room temperature for 30 min in dark. The reduced and
alkylated samples were immobilized in 100 µL of 10% SDSPAGE gel. The gel pieces containing immobilized samples
were transferred into 2 mL, 0.45 μm hydrophilic PVDF, a
filter-bottom 96-well microplate. Then, the samples were
washed with 1 mL of 20 mM NaHCO3, pH 7.2 followed
by 1 mL of acetonitrile. This washing step was repeated 5
times. The samples were dried using vacuum centrifuge.
Then, the N-glycans in the immobilized samples were
cut off using the PNGase F enzyme according to the
procedure suggested by the producer. The N-glycans
detached from proteins were collected in a 2 mL squaretapered polypropylene 96-well plate by washing the gel
pieces 3 times with 200 mL of water followed by washing
3 times with 200 mL of acetonitrile. The collected samples
were dried and treated with 20 µL of 1% acetic acid at
room temperature for 40 min to open the reducing end of
the glycans. These reducing ends that were opened were
labeled with 2-aminobenzamide (2AB) using a LudgerTag
2AB labeling kit. The 2AB-labeled N-glycans were
transferred onto a Whatman 3MM chromatography paper
and placed into a 96-well plate. Following washing 5 times
with 2 mL of acetonitrile, the labelled and cleaned glycans
were eluted with 0.9 mL of water twice. The samples were
then dried, resuspended in water, and separated on a
TSKgel Amide-80 column (4.6 mm in internal diameter
and 25.0 cm in length) attached to HPLC with the gradient
of ammonium format (35% → 47%): acetonitrile (65% →

53%) in 60 min (Royle et al., 2008). The quantitative data
for the G0F, G0FB, and G1t glycans were obtained from
the areas under each glycan peak.
2.4. Statistical analysis
The differences between the patient and control groups were
analyzed using the Student’s t-test. The normal distribution
of the data groups was analyzed using the Shapiro–Wilk
test. According to the results, all the groups used here had
a normal distribution. Therefore, the correlations of the
G0t, G0F, and G0FB glycans with Das28-CRP3 disease
activity were analyzed by the Spearman’s rho value.
3. Results
3.1. The use of GOF and G0FB glycan structures by IgG
in serum
Here, the glycan profiles obtained from 3 samples are
examined in detail. According to the comparison of the
protein G-purified IgG glycan profile with serum alone
and the IgG-depleted serum N-glycan profiles, the G0
structures in the serum N-glycan profile mainly originate
from IgG, while the G2 glycan structures has a significant
contribution from other proteins in the serum (Figure 2a).
In the detailed examination of the G0 glycan structures,
the G0F and G0FB glycan structures that make up the G0t
glycans had contributions from different glycoproteins
in the serum (Figure 2b). When the N-glycan profile
of the serum samples (n = 9) was compared with that
of the matched IgG-depleted serum sample, the G0F
glycan structure (14.3 ± 6.7%) and the G0FB structure
(64.48 ± 7.4%) originated from other glycoproteins in the
serum. After determining the contributions from serum
glycoproteins to the IgG G0F and G0FB glycans, the sex
dependency of the correlation of the G0F and G0FB glycan
structures with the collective disease actives score Das28CRP3 was examined.
3.2. Contributions of G0F and G0FB glycan structures to
G0t phenotype in RA
The contribution of the G0F and G0FB glycan structures to
the G0t phenotype in RA was examined. In healthy controls
(n = 232), G0t (1.01 ± 0.23) was composed of 0.61 ± 0.19
G0F and 0.40 ± 10 G0FB structures (Figure 3a). In RA
patients (n = 232), G0t (1.36 ± 0.41) was composed of 0.85
± 0.34 G0F and 0.50 ± 0.13G0FB structures. Although the
contribution of G0F (~61%) and G0FB (~39%) structures
to G0t in RA patients and healthy controls did not differ
in percentage, the quantities of G0F (average ± SD, 0.85
± 0.34 vs. 0.61 ± 0.19; P < 0.0001) and G0FB (average ±
SD, 0.50 ± 0.13 vs. 0.40 ± 0.10; P < 0.0001) structures were
statistically different (Figure 3a). These data show that
the G0F and G0FB glycan structures together contribute
to the G0t phenotype in RA disease compared to healthy
controls and both the G0F and G0FB glycan structures are

409

ERCAN / Turk J Biol
different in RA patients compared to healthy controls (P <
0.0001) (Figure 3a).
3.3. Correlation of G0F and G0FB N-glycan structures
with Das28-CRP3 is sex-dependent
When the known correlation of the G0t glycan structures
with Das28-CRP3 is examined for G0F and G0FB, both
glycan structures have different correlations with Das28CRP3. The correlation of the G0F structure (Spearman ρ =
0.34, P < 0.0001) is higher than that of the G0FB structure
(Spearman ρ = 0.24, P = 0.0001) (Figure 3b). When this data
is stratified by sex, the G0F glycan structure (P = 0.0058)

is statistically different while the G0FB glycan structure
(P = 0.38) is not statistically different (Figure 4a). Further
examination for the correlations of the G0t, G0F, and G0FB
glycan structures with Das28-CRP3 yields the values for
G0t (Spearman’s ρ = 0.60, P < 0.0001), G0F (Spearman’s
ρ = 0.60, P < 0.0001), and G0FB (Spearman’s ρ = 0.53, P
<0.0001). When the sex dependence of these correlations is
investigated, the structures of G0t (Spearman’s ρ = 0.60, P <
0.0001), G0F (Spearman’s ρ = 0.53, P < 0.0001), and G0FB
(Spearman’s ρ = 0.39, P < 0.0001) have strong correlations
in female RA patients while G0t (Spearman’s ρ = 0.16, P =

Figure 2. Characterization of IgG N-glycans in serum samples. (A) Shown are N-glycan profiles of serum (brown), IgG-depleted
(yellow) and purified IgG (black) samples, and peaks of G0F, G0FB and G1t glycan structures to which the peaks belong. (B) The areas
under the G0F and G0FB peaks are calculated from serum and IgG isolated serum samples and summarized in the graph above.

Figure 3. Contributions of G0F and G0FB glycan structures to the correlation between G0t phenotype and Das28-CRP3. (A) The
% values of G0t, G0F and G0FB glycansin RA patients (n = 232) were compared that of healthy human (H) samples (n = 232) using
Student’s t-test, and they are all statistically different. (B) The correlation of G0F (circle, dashed line, and n = 226) and G0FB (triangle,
straight line, and n = 226) glycan structures with Das28-CRP3 was presented and assessed using the Spearman rank coefficient method.
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0.1032), G0F (Spearman’s ρ = 0.180, P = 0.1327), and G0FB
(Spearman’s ρ = 0.080, P = 0.4146) do not correlate in male
RA patients (Figure 4b). Therefore, the correlation of G0t
with Das28-CRP3 originates from both the G0F and G0FB
glycan structures, but this correlation is sex-dependent.
3.4. The effect of menopause on the correlation of G0t,
G0F, and G0FB with Das28-CRP3
The effect of menopause on the correlation of the G0t,
G0F, and G0FB glycan structures with Das28-CRP3 is
investigated. For menopause, the age of 50 is accepted as
a critical age and female RA patients aged 50 years and
below are classified as premenopause and those aged above
50 years as postmenopause. According to the results, the
G0t glycan structure has correlations with Das28-CRP3 in
the premenopause (Spearman’s ρ = 0.63, P < 0.0001) and
postmenopause (Spearman’s ρ = 0.57, P < 0.0001) groups
(Figure 5). The G0F glycan structure correlates with Das28CRP3 in premenopause (Spearman’s ρ = 0.43, P = 0.011)
and postmenopause (Spearman’s ρ = 0.51, P < 0.0001)
(Figure 5). Likewise, the G0FB glycan structure correlates

with Das28-CRP3 in the premenopause (Spearman’s ρ
= 0.46, P = 0.0061) and postmenopause (Spearman’s ρ =
0.32, P = 0.0031) groups (Figure 5). Although all the IgG
glycan structures examined here differ in their level of
correlations with Das28-CRP3, they all have statistically
significant correlations.
4. Discussion
The immune system differs in men and women, and the
reason for this is not fully understood to date (Klein,
2012a; Klein, 2012b; Ngo et al., 2014; Rainville et al., 2018;
Dolsen et al., 2019). A good example for this is that RA
disease affects females more than males with a ratio of 3/1.
The studies with pregnant RA patients, whose estrogen
level peaks, point to the relationship between the G0t
glycan structures and the Das28-CRP disease activity. In
this patient group, as the level of the G0t glycan structure
decreases, the Das28-CRP3 score decreases (Reiding et
al., 2017; Bondt et al., 2018). Recent research aligned with
this observation proves that the sex hormone estrogen

Figure 4. Sex dependent differences of the IgG G0t, G0F and G0FB glycan structures and the correlations with Das28-CRP3. (A) The
distribution of G0t (left), G0F (middle) and G0FB (right) glycan structures in women (F, red, n = 119) and men (M, blue, n = 107) are
shown above. The presence of differences of G0t, G0F and G0FB between M and F was evaluated using Student's t-test. (B) Correlation
of these glycan structures with Das28-CRP3 in women (red circles and line) and men (blue circles and line) is shown.
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Figure 5. The effect of menopause on the correlation of IgG G0t, G0F and G0FB glycan structures with Das28-CRP3. In the graphs above,
the correlations of G0t (left), G0F (middle) and G0FB (right) glycan structures with Das28-CRP3 are evaluated using the Spearman rank
coefficient method and shown as premenopause (red circle and line, n = 34) and postmenopause (black circle and line, n = 85).

regulates the distribution of IgG glycan structures in
vivo (Ercan et al., 2017). Because of these observations, a
detailed investigation was performed on the relationship
between different proinflammatory G0F and G0FB glycan
structures and Das28-CRP3. The data presented here show
that IgG-dependent inflammation in females and males
contributes to the sex dichotomy in the immune system
by utilizing different distribution of the IgG Fc glycan
structures in males and females.
The glycan analysis was performed using the HPLC
based serum N-glycan analysis (Royle et al., 2008). In the
serum, more than 50% of the proteins in the human body
contain glycosylation (Apweiler et al., 1999). In parallel,
the serum N-glycan profile is also a complex glycan
mixture profile, and different proteins may contain the
same glycan structures as in IgG and fibrinogen (Ercan et
al., 2010; Adamczyk et al., 2013; Adamczyk et al., 2017).
IgG and fibrinogen glycoproteins contribute to the serum
N-glycan profile with two-antenna complex N-glycan
structures. Although the fibrinogen N-glycan profile is
more processed and predominantly capped with sialic
acid structure compared to the IgG N-glycan profile, IgG
has more diverse glycan structures—at least 36 glycan
structures—which are more evenly distributed ( Royle
et al., 2006; Adamczyk et al., 2013). Thus, to examine
the contribution of the IgG N-glycan structures to the
serum N-glycan profile, 3 samples were generated as the
serum, IgG-depleted serum, and protein G-purified IgG,
which were characterized using the HPLC-based serum
N-glycan analysis method (Royle et al., 2008). When
the IgG-isolated serum N-glycan and serum N-glycan
profiles were compared, 86% of the G0F glycan structure
originated from IgG while 36% of the G0FB structure
originated from IgG. Therefore, it is reasonable to consider
the data obtained for the G0F glycan structure using serum
N-glycan profile heavily belongs to IgG in the serum.
The G0F and G0FB glycan structures contribute to
the G0t phenotype in RA patients (Figure 3a), and both
the G0F and G0FB glycan structures have correlations
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with Das28-CRP3 (Figure 3b). However, when RA
patients are stratified by sex, the G0F glycan structure is
expressed differently in males and females while the G0FB
glycan structure is not (Figure 4a). In addition, when the
correlations of the G0F and G0FB glycan structures with
Das28-CRP3 are examined, there is a tight correlation in
females but not in males. Therefore, these results indicate a
new axis of sex-dependent regulation of inflammation via
the G0F glycan structure.
To understand the effect of estrogen on the correlations
of the G0F and G0FB glycan structures with Das28CRP3 in more detail, the effect of sex and menopause
is investigated. The G0F glycan structure has a strong
correlation with Das28-CRP3 in females but not in males,
indicating that IgG glycosylation, more specifically the
G0F glycan structure, contributes to the sex dichotomy
in RA and IgG-dependent inflammation. When the
effect of menopause, which is an important turning point
in hormonal levels in the life of women, is investigated,
the G0F and G0FB glycan structures surprisingly have
correlations with Das28-CRP3 in both premenopause
and postmenopause. This can be due to the estrogen
supplement taken by postmenopausal females (Engdahl et
al., 2018). The results presented here and the data in the
literature grant a more detailed investigation to dissect the
effect of menopause on the association of G0F and G0FB
with Das28-CRP3 (Ercan et al., 2017; Reiding et al., 2017;
Bondt et al., 2018).
In general, the sex hormone estrogen modulates IgG
glycosylation and therefore the communication between
the adaptive and innate arms of the immune system
(Ercan et al., 2017). IgG plays an important role in the
activation of the innate system, the other arm of the
immune system, through interaction with FcgR and the
complement fragment C1q molecules (Nicholson, 2016).
The importance of IgG binding to FcgR and C1q molecules
has been proven without doubt in RA mouse models. In
RA mouse models, the transfer of anti-CCP and anti-GPI
pathogenic autoantibodies purified from sick mice to
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healthy mice has been shown to cause inflammation and
related destruction of bone and cartilage in small joints,
and this proinflammatory effect of IgG disappears with
the removal of IgG Fc glycan (Allhorn et al., 2010; Lood
et al., 2012). Therefore, the proinflammatory effect of IgG
depends on the N-glycan structure in the IgG Fc fragment
and is critical for this process. Based on the data presented
here about the differential correlation of the IgG glycan
structures with Das28-CRP3 in women and men, the sexdependent regulation of the proinflammatory property of
IgG depends on IgG Fc glycosylation, which is regulated
by hormones. In conclusion, the communication between

innate and adaptive immune systems through the IgG Fc
glycan structures is differentially regulated in men and
women via IgG glycosylation, more specifically the G0F
glycan structure.
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